09:58 AM EST - Endo International plc : Has initiated a restructuring program. These restructuring actions primarily relate to the Company's Corporate functions and Branded pharmaceutical R&D functions in Malvern, PA and Chestnut Ridge, N.Y. The restructuring program will better align these parts of our organization in size and scope with the Company's recently restructured Generics and U.S Branded Pharmaceutical business units. Endo International plc
shares T.ENDP are trading up $0.17 at $15.72.
